In March 2015, a Pennsylvania jury awarded a Wisconsin family a $3 million award in a Topamax birth defects lawsuit. The suit, which the family filed in December 2011, alleged that Johnson & Johnson, and the subsidiary Janssen Pharmaceuticals, failed to warn patients and health care providers about the birth defects risks associated with using Topamax while pregnant.
The family presented their case in the Philadelphia County Court of Common Pleas. The mother used Topamax during her pregnancy to treat chronic migraines. The family’s child was born with a cleft lip, which they claim is the result of the child’s exposure to Topamax in the womb.
According to a Law360 article on the Topamax lawsuit, about 3.8% of children exposed to Topamax in the womb develop an oral birth defect. Unfortunately, the risk of developing a cleft lip or a cleft palate is high for these children.
Johnson & Johnson and Janssen Pharmaceuticals expressed empathy for the family in the case. However, the defendants said that they made the decision to appeal the jury’s $3 million verdict.
They felt that the jury didn’t account for other factors that may have influenced the child’s development of a cleft lip.
Carey Danis & Lowe works with families whose children have been injured by Topamax in the womb. Our team of defective drug lawyers is dedicated to recovering losses for these families.
Our lawyers are available to help you. We offer free case evaluations, during which we discuss your case, your compensation eligibility, and whether filing a Topamax birth defects lawsuit is right for you and your family.
The Carey Danis & Lowe staff also includes medical professionals, who are available to answer your questions about Topamax birth defects.
You can reach our law offices by phone at 800.721.2519, or by completing a confidential personal injury claim form.
We look forward to offering you any assistance that we can.
Continue to read the Carey Danis & Lowe blog for Topamax lawsuit updates. You may be interested in reading:
References: Pharmaceutical litigation, Topamax